info@mail.ucallm.com
From Chromatin Control to Gene Expression Programs — Empowering Precision Investigation of Transcriptional Networks, Cell Identity, and Disease Mechanisms with Validated Antibody Solutions
Transcriptional regulation represents a fundamental layer of biological control that integrates chromatin accessibility, epigenetic modifications, signaling pathways, and transcription factor activity to define cellular identity, function, and adaptation.
Dynamic transcription factor networks regulate diverse biological processes, including:
· Cell fate determination and lineage specification
· Stem cell maintenance and cellular reprogramming
· Developmental patterning and tissue homeostasis
· Immune activation and inflammatory responses
· Metabolic adaptation and stress responses
· Tumor initiation, progression, and therapeutic resistance
Transcription factors function together with epigenetic regulators, chromatin remodelers, and transcriptional co-regulators to establish gene expression states. Dysregulation of these networks contributes to major diseases, including cancer, immune disorders, neurodegeneration, metabolic disease, and fibrosis.
We provide comprehensive antibody solutions for investigating transcriptional regulation—from pioneer transcription factors and chromatin-associated regulators to lineage-specific transcription programs and disease-associated transcriptional reprogramming.
Validated antibodies support researchers in:
· Mapping transcription factor networks
· Characterizing cell identity and differentiation states
· Investigating epigenetic regulation of gene expression
· Profiling disease-associated transcriptional signatures
· Evaluating therapeutic targets and pathway modulation
Transcription Regulation & Transcription Factor Biomarker Antibody Portfolio
—Comprehensive Solutions for Chromatin Regulation, Transcriptional Control, Cellular Identity, and Disease-Associated Gene Programs
Transcriptional regulation is governed by coordinated interactions among DNA-binding transcription factors, epigenetic enzymes, chromatin readers, and signaling-responsive regulators.
Our validated antibody portfolio targets key regulatory networks involved in:
Research Focus | Representative Biomarkers | Research Applications |
Chromatin Architecture & Transcriptional Regulation | CTCF, BRD4, EZH2, HDAC7, NFYA, NFYB, NFYC | Investigation of chromatin organization, enhancer regulation, transcriptional activation/repression |
Signal-Responsive Transcription Factors | STAT3, p-STAT3 (Tyr705), p65, p-p65 (Ser536), CREB1, p-CREB1 (Ser133), NFATC1, HIF1A | Analysis of cytokine signaling, inflammation, hypoxia adaptation, and stress-responsive transcription |
Oncogenic Transcription Programs | MYC, MAX, TP53, GLI1 | Characterization of tumor evolution, proliferation, metabolism, and cancer-associated transcriptional changes |
Epigenetic Transcriptional Control | BRD4, EZH2, HDAC1/2/7, PRDM1, PRDM14 | Profiling chromatin remodeling, transcriptional repression, and epigenetic reprogramming |
Stemness & Cellular Reprogramming | OCT4, SOX2, KLF4, PRDM14 | Investigation of pluripotency maintenance, regeneration, and induced cellular identity changes |
Lineage-Specific Transcription Regulation | FOXA1, FOXA2, FOXA3, GATA3, MITF | Analysis of tissue specification, pioneer factor activity, and lineage commitment |
Metabolic & Lysosomal Transcription Programs | TFEB, TFE3, MITF | Study of lysosomal biogenesis, autophagy regulation, and metabolic adaptation |
Transcriptional Master Regulators Network
—Key Transcription Factors Coordinating Cell Identity, Environmental Adaptation, and Disease Progression
Transcription factors act as molecular switches that integrate extracellular signals, intracellular stress, and epigenetic states to establish stable gene expression programs.
Our antibody solutions enable comprehensive analysis of major transcriptional regulatory axes:
Key Target | Biological Role | Antibody Research Application |
CTCF | Master chromatin organizer regulating genomic architecture, enhancer–promoter communication, and transcriptional insulation | Analysis of 3D genome organization and chromatin domain regulation |
BRD4 | Bromodomain-containing chromatin reader recognizing acetylated histones and promoting transcriptional activation | Investigation of enhancer activity, inflammatory transcription, and cancer-associated transcription programs |
EZH2 | Catalytic component of PRC2 responsible for H3K27 methylation and transcriptional repression | Profiling epigenetic silencing and tumor-associated chromatin remodeling |
STAT3 | Cytokine-responsive transcription factor regulating inflammation, immunity, survival, and proliferation | Evaluation of JAK/STAT signaling activation and immune disease mechanisms |
NF-κB | Central inflammatory transcription regulator controlling cytokine and immune response genes | Analysis of chronic inflammation, immune activation, and cancer microenvironment |
HIF-1α | Oxygen-sensitive transcription factor controlling hypoxia adaptation, angiogenesis, and metabolism | Detection of hypoxic signaling and metabolic reprogramming |
c-MYC | Master oncogenic transcription factor regulating proliferation, metabolism, and biosynthesis | Investigation of MYC-driven tumor growth and metabolic dependency |
TP53 | Tumor suppressor transcription factor controlling DNA damage response, apoptosis, and cell-cycle arrest | Characterization of genomic stress responses and cancer biology |
GLI1 | Hedgehog pathway transcriptional effector controlling developmental and disease-associated gene expression | Analysis of Hedgehog signaling activation and tumor progression |
TFEB | Master transcriptional regulator of lysosomal biogenesis and autophagy programs | Investigation of cellular clearance mechanisms and metabolic adaptation |
TFE3 | Transcription factor regulating lysosomal function, autophagy, and energy metabolism | Study of nutrient sensing and stress-responsive transcription |
FOXA1 | Pioneer transcription factor opening chromatin and enabling lineage-specific gene regulation | Investigation of tissue identity and hormone-responsive transcription |
FOXA2 | Pioneer factor controlling endoderm development and metabolic tissue specification | Analysis of developmental transcription programs |
SOX2 | Core pluripotency transcription factor maintaining stem cell identity | Study of stemness, regeneration, and cellular reprogramming |
OCT4/POU5F1 | Essential pluripotency regulator maintaining embryonic stem cell characteristics | Identification of stem-cell states and reprogramming efficiency |
GATA3 | Lineage-specific transcription factor controlling immune and epithelial differentiation | Analysis of T-cell differentiation and tissue identity programs |
MITF | Master regulator of melanocyte, lysosomal, and immune-associated transcription programs | Investigation of pigmentation biology, lysosomal regulation, and disease-associated macrophage states |
Featured Transcription Regulation Research Panels
—Integrated Antibody Solutions for Decoding Gene Regulatory Networks, Cellular Identity, and Disease-Associated Transcriptional Remodeling
Transcriptional dysregulation is a defining feature of many pathological states. Integrated biomarker panels enable researchers to investigate transcription factor activation, epigenetic regulation, and disease-associated gene expression programs.
n Chromatin Remodeling & Epigenetic Transcription Panel—Mapping transcriptional accessibility and chromatin regulation
Key Markers
CTCF | BRD4 | EZH2 | HDAC1 |
HDAC2 | HDAC7 | H3K27me3 | Acetyl-Histone H3 |
n Cancer Transcriptional Reprogramming Panel—Decoding oncogenic transcription networks driving tumor evolution
Key Markers
c-MYC | MAX | TP53 | STAT3 | NF-κB | HIF-1α | GLI1 |
n Stemness & Cellular Reprogramming Panel—Characterizing cell identity transitions and regenerative programs
Key Markers
OCT4 | SOX2 | KLF4 | PRDM14 | PRDM1 |
n Immune & Inflammatory Transcription Panel—Profiling immune activation and inflammatory gene programs
NF-κB | STAT3 | NFATC1 | GATA3 | CREB1 |
n Metabolic Stress & Lysosomal Transcription Panel—Investigating cellular adaptation and metabolic homeostasis
Key Markers
TFEB | TFE3 | MITF | HIF-1α | NRF2 |
Why Researchers Choose Our Transcription Regulation & Transcription Factor Antibody Solutions
Validated Transcription Targets. Comprehensive Regulatory Networks. Reliable Biological Insights.
Our antibody portfolio enables researchers to move beyond single-marker detection toward integrated analysis of transcriptional regulation across diverse biological systems.
Research Challenge | Our Solution |
How can I analyze transcription factor activation? | Phosphorylation and expression-specific antibodies targeting STAT3, NF-κB, CREB1, HIF-1α pathways |
How can I study chromatin-mediated transcription regulation? | CTCF, BRD4, EZH2, HDAC and histone modification antibody solutions |
How can I investigate cancer transcription networks? | MYC, TP53, STAT3, GLI1 oncogenic transcription panels |
How can I characterize stemness and cellular identity? | OCT4, SOX2, KLF4, FOXA pioneer factor panels |
How can I study metabolic transcription adaptation? | HIF-1α, TFEB, TFE3, MITF metabolic regulation markers |
How can I perform spatial transcriptional profiling? | Multiplex IF/IHC-compatible validated transcription factor antibodies |
Key reference
1. Yu G, Xu K, Xia W, Zhang K, Xu Q, Li L, Lin Z, Liu L, Liu B, Du Z, Chen X, Fan Q, Lai F, Wang W, Wang L, Kong F, Wang C, Dai H, Wang H, Xie W. Establishment of chromatin architecture interplays with embryo hypertranscription. Nature. 2025 Oct;646(8083):208-217.
2. Sugo N, Atsumi Y, Yamamoto N. Transcription and epigenetic factor dynamics in neuronal activity-dependent gene regulation. Trends Genet. 2025 May;41(5):425-436.
3. Matsui S, Granitto M, Buckley M, Ludwig K, Koigi S, Shiley J, Zacharias WJ, Mayhew CN, Lim HW, Iwafuchi M. Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate. Mol Cell. 2024 Feb 1;84(3):476-489.e10.
4. Wu H, Hou X, Zhang C. Nuclear factor-Y transcription factors in crops: Biological roles, regulation, and breeding applications. Plant Commun. 2025 Nov 10;6(11):101530.
5. Liu S, Cao Y, Cui K, Ren G, Zhao T, Wang X, Wei D, Chen Z, Gurram RK, Liu C, Wu C, Zhu J, Zhao K. Regulation of T helper cell differentiation by the interplay between histone modification and chromatin interaction. Immunity. 2024 May 14;57(5):987-1004.e5.
6. Balak CD, Schlachetzki JCM, Lana AJ, West E, Hong C, DuGal J, Zhou Y, Li B, Spann NJ, Saisan P, Sarsani V, Kleemann KL, Zhang X, Pasillas MP, O'Brien S, Bokor JA, Gordts PLSM, Butovsky O, Stevens B, Kamme F, Glass CK. Lysosomal dysfunction drives a transcriptional and epigenetic signature found in disease-associated microglia in neurodegenerative diseases. Immunity. 2026 Aug 11;59(8):2142-2163.e8.